Low-dose aspirin may limit cancer metastasis by inhibiting platelet activation and enhancing T-cell immunity, supporting biomarker guided use while balancing bleeding risk overall.
Real-world immune-related adverse events in patients with early triple negative breast cancer who received pembrolizumab. Prevention of sacituzumab govitecan (SG)-related neutropenia and diarrhea in ...
Cancer Risks Associated With TP53 Pathogenic Variants: Maximum Likelihood Analysis of Extended Pedigrees for Diagnosis of First Cancers Beyond the Li-Fraumeni Syndrome Spectrum Data for 239 patients, ...
Lymphocyte-depleted Hodgkin’s lymphoma (LDHL) is a rare subtype of Hodgkin’s lymphoma, a cancer that develops in the lymphatic system. Hodgkin’s lymphoma (HL) is an uncommon cancer of the lymphatic ...
Cancer is the second leading cause of death worldwide. It accounts for an estimated 9.6 million deaths, or 1 in 6 deaths, in 2018, according to the World Health Organization (WHO). The numbers are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results